Hostname: page-component-848d4c4894-v5vhk Total loading time: 0 Render date: 2024-06-24T21:50:59.915Z Has data issue: false hasContentIssue false
  • English
  • Français

Intrathecal Baclofen for Intractable Spinal Spasticity – a Double-blind Cross-over Comparison with Placebo in 6 Patients

Published online by Cambridge University Press:  18 September 2015

H. Hugenholtz ,
R.F. Nelson ,
E. Dehoux  and
R. Bickerton
H. Hugenholtz*
Affiliation:
Ottawa General Hospital, Royal Ottawa Rehabilitation Centre, Ottawa
R.F. Nelson
Affiliation:
Ottawa General Hospital, Royal Ottawa Rehabilitation Centre, Ottawa
E. Dehoux
Affiliation:
Ottawa General Hospital, Royal Ottawa Rehabilitation Centre, Ottawa
R. Bickerton
Affiliation:
Ottawa General Hospital, Royal Ottawa Rehabilitation Centre, Ottawa
*
Ottawa General Hospital, Room 6353, 501 Smyth Road, Ottawa, Ontario, Canada KIH 8L6
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A group of six subjects with intractable spinal spasticity completed a double-blind cross-over paradigm in which they received two intrathecal bolus injections of baclofen solution five hours apart on two different days and two intrathecal bolus injections of placebo saline five hours apart on two other days. Each subject was repeatedly tested with a battery of clinical and physiological tests. In contrast to the placebo injections, the group responded to the baclofen injections with subjective and objective, clinically significant improvement in parameters of spasticity in their lower limbs, including muscle tone, frequency of spasms, hyperreflexia and passive range of joint motion. Furthermore, this improvement was maintained following thirty consecutive days of intrathecal bolus injections of baclofen at a fixed dose.

Type
Articles
Information
Canadian Journal of Neurological Sciences , Volume 19 , Issue 2 , May 1992 , pp. 188 - 195
Copyright
Copyright © Canadian Neurological Sciences Federation 1992

References

1.Bowery, NG, Hill, DR, Hudson, AL, et al. Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature 1980; 283: 92–84.CrossRefGoogle Scholar
2.Young, RR, Delwaide, PJ.Drug therapy: spasticity. N Engl J Med 1981; 304 (2): 96–99.Google ScholarPubMed
3.Knuttson, E, Lindblom, U, Martenson, A.Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimal therapeutic responses in spastic paresis. J Neurol Sci 1974; 23: 473–484.Google Scholar
4.Kroin, JS, Penn, RD, Beissinger, RL, et al. Reduced spinal reflexes following intrathecal baclofen in the rabbit. Exp Brain Res 1984; 54: 19–194.Google ScholarPubMed
5.Penn, RD, Kroin, JS.Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1984; 1: 1078.Google ScholarPubMed
6.Yaksh, TL, Reddy, SVR.Studies on the analgesic effects of intrathecal opiates, alpha-adrenergic agonists and baclofen: their pharmacology in the primate. Anesthesiology 1981; 54: 451–467.CrossRefGoogle ScholarPubMed
7.Armstrong, R, Sykanda, A, Steinbok, P, et al. A pilot study of intrathecal baclofen for treatment of spasticity in children. American Academy for Cerebral Palsy and Developmental Medicine, Boston, Mass. October 7–10, 1987.Google Scholar
8.Dralle, D, Muller, H, Zierski, J, et al. Intrathecal baclofen for spasticity. Lancet 1985; 2: 1003.Google ScholarPubMed
9.Hankey, GJ, Stewart-Wynne, EG, Perlman, D.Intrathecal baclofen for severe spasticity. Med J Aust 1986; 145: 465–466.CrossRefGoogle ScholarPubMed
10.Lazorthes, Y.Chronic intrathecal administration of baclofen in the treatment of severe spasticity. In: Muller, H, Zierski, J, Penn, RD, eds. Local-spinal Therapy of Spasticity. Berlin: Springer-Verlag 1988; 215–222.CrossRefGoogle Scholar
11.Muller, H, Borner, U, Zierski, J, et al. Intrathecal baclofen in tetanus. Lancet 1986; 1:317–318.CrossRefGoogle ScholarPubMed
12.Muller, H, Borner, U, Zierski, J, et al. Intrathecal baclofen for treatment of tetanus-induced spasticity. Anesthesiology 1987; 66: 76–79.CrossRefGoogle ScholarPubMed
13.Muller, H, Zierski, J.Long-term continuous intrathecal baclofen infusion. In: Marsden, CD, ed. Treating Spasticity: Pharmacologic Advances. Toronto: Hans Huber 1989; 55–68.Google Scholar
14.Ochs, G.Intrathecal application of baclofen (Lioresal) in spasticity. In: Marsden, CD, ed. Treating Spasticity: Pharmacologic Advances. Toronto: Hans Huber 1989; 49–54.Google Scholar
15.Penn, RD.Chronic intrathecal baclofen for severe rigidity and spasms. In: Muller, H, Zierski, J, Penn, RD, eds. Local-spinal Therapy of Spasticity. Berlin: Springer-Verlag 1988; 151–154.CrossRefGoogle Scholar
16.Penn, RD, Kroin, JS.Continuous intrathecal baclofen for severe spasticity. Lancet 1985; 2: 125–127.CrossRefGoogle ScholarPubMed
17.Penn, RD, Kroin, JS.Long-term intrathecal baclofen infusion for treatment of spasticity. J Neurosurg 1987; 66: 181–185.CrossRefGoogle ScholarPubMed
18.Siegfried, J, Lazorthes, Y.Neuropharmacologie en administration intrathecale. Neurochirurgie 1985; 31 (Suppl 1): 95–101.Google Scholar
19.Penn, RD, Savoy, SM, Corcos, D, et al. Intrathecal baclofen for severe spinal spasticity. N Eng J Med 1989; 320 (23): 1517–1521.CrossRefGoogle ScholarPubMed
20.Katz, RT, Rymer, WZ.Spastic hypertonia: mechanisms and measurement. Arch Phys Med Rehabil 1989; 70: 144–155.Google ScholarPubMed
21.Hugenholtz, H, Humphreys, P, Mclntyre, WMJ, et al. Cervical spinal cord stimulation for spasticity in cerebral palsy. Neurosurgery 1988; 22 (4): 707–714.Google ScholarPubMed
22.Davis, R, Gray, E, Kudzma, J.Beneficial augmentation following dorsal column stimulation in some neurological disease. Appl Neurophysiol 1981; 44: 37–49.Google Scholar
23.Waltz, JM.Computerized percutaneous multi-level spinal cord stimulation in motor disorders. Appl Neurophysiol 1982; 45: 73–92.Google ScholarPubMed
24.Bohannon, RW, Smith, MB.Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67 (2): 206–207.CrossRefGoogle ScholarPubMed
25.Hattab, JR.Review of European clinical trials with baclofen. In: Feldman, RG, Young, RR, Koella, WP, eds. Spasticity: Disordered Motor Control. Miami: Symposia Specialists 1980; 71–75.Google Scholar
26.Joint Motion: Method of Measuring and Recording. American Academy of Orthopedic Surgeons. Edinburgh: Churchill Livingstone 1965.Google Scholar
27.DeJong, RN.The Neurologic Examination, 2nd Edition. New York: Hoeber & Harper 1958; 425.Google Scholar
28.Smith, HB.Smith hand function evaluation. Am J Occup Ther 1978; 27 (5): 244–251.Google Scholar
29.Shahani, BT, Young, RR.The flexor reflex in spasticity. In: Feldman, RG, Young, RR, Koella, WP, eds. Spasticity: Disordered Motor Control. Chicago: Yearbook 1980; 287–295.Google Scholar
30.Little, JW, Micklesen, P, Umlauf, R, et al. Lower extremity manifestations of spasticity in chronic spinal cord injury. Am J Phys Med & Rehab 1989; 68 (1): 32–36.CrossRefGoogle ScholarPubMed
31.Young, RR, Wiegner, AW.Spasticity. Clin Orthop 1987; 219: 50–62.CrossRefGoogle Scholar
32.Ochs, G, Struppler, A, Meyerson, BA, et al. Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study. J Neurol Neurosurg Psychiatry 1989; 52: 933–939.CrossRefGoogle ScholarPubMed
33.Latash, ML, Penn, RD, Corcos, DM, et al. Effects of intrathecal baclofen on voluntary motor control in spastic paresis. J Neurosurg 1990; 72: 388–392.Google ScholarPubMed
34.Penn, RD, Kroin, JS.Intrathecal baclofen, (letter). N Engl J Med 1989; 321 (20: 1414–1415.Google Scholar
35.Hankey, GJ, Stewart-Wynne, EG, Perlman, D.Intrathecal baclofen for severe spasticity (letter). Med J Aust 1987; 147 (5): 261.Google Scholar
36.Leavens, ME, Hill, CS, Cech, DA, et al. Intrathecal and intraventricular morphine for pain in cancer patients: initial study. J Neurosurg 1982; 56: 241–245.Google ScholarPubMed
37.Lazorthes, Y, Sallerin-Caute, B, Verdie, JC, et al. Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg 1990; 72: 393–402.Google ScholarPubMed
38.Ochs, G, Strupler, A.Treatment of spasticity by implantable drug administration devices and intrathecal catheters. In: Benecke, R, Conrad, B, Marsden, CD, eds. Motor Disturbances I. Toronto: Academic Press 1987; 197–207.Google Scholar